skip to content

Investors

Roche’s Pharma Day 2025

Monday, 22nd September 2025, 09:00am BST

More details

3D illustration of colorful molecules with clustered blue and red spheres on a blurred brown-orange background, conveying a scientific and dynamic feel.

24 million

patients were treated with Roche medicines in 2024

30 billion

Roche Diagnostics test were delivered to customers worldwide in 2024

+1%

Core investments in research and development in 2024: CHF 13.2 billion

Our two divisions are focusing jointly on three disease areas that will account for almost 50% of the global disease burden by 2035: cancer, cardiovascular-metabolic diseases and neurological diseases.

Portrait of Thomas Schinecker

Dr Thomas Schinecker

CEO Roche Group

Upcoming Investor events

View all events

22nd Annual Goldman Sachs European Medtech and Healthcare Services ConferenceInvestors

September 04, 2025 at 08:00 BST | London, UK

Morgan Stanley 23rd Annual Global Healthcare ConferenceInvestors

September 09, 2025 at 08:30 EST | New York, US

Nephron Napa Summit 2025Investors

September 17, 2025 at 10:00 PDT | Yountville, US

Roche's Pharma Day 2025Investors

September 22, 2025 at 09:00 BST | London, UK

Bank of America Global Healthcare ConferenceInvestors

September 25, 2025 at 10:00 BST | London, UK

JP Morgan CEO Conference Call SeriesInvestors

September 26, 2025 at 16:00 CEST | Basel, Switzerland

Investor relations team contacts

Do you need to get in touch with us? Reach out to our investor relations team with your enquiries.